Ph1 FIH Study of TORL-1-23 in CLDN6+ GYN NSCLC & Solid Participants

Phase I Clinical Trial

A PHASE 1 FIRST IN HUMAN DOSE-ESCALATION STUDY OF TORL-1-23 IN PARTICIPANTS WITH ADVANCED CANCER (TORL123-001)

Indication: Lung Cancer, Lung Cancer, Ovarian Cancer, Ovarian Cancer
Trial Number: 05103683
Trial Status: Call Proj Mgr

Learn more about this clinical trial.

Participating Locations